You are here: Home :: Keyword index :: α-Is bis atr :: Aspirin - ataxia Aspirin

Items for "Aspirin"

Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients

The antiplatelet effect of aspirin varies individually. This study evaluated whether the antiplatelet effect of aspirin associates with polymorphisms in the genes coding for cyclo-oxygenase-1 (COX-1) and several platelet glycoprotein (GP) receptors in patients with stable coronary artery disease (CAD)...

Keywords: Aspirin, cyclo-oxygenase-1, genotype, glycoprotein VI, coronary artery disease

00/0000 | Thrombosis and Haemostasis, Schattauer

Biological efficacy of low against medium dose aspirin regimen after coronary surgery: Analysis of platelet function

The failure of aspirin to inhibit platelet function has been documented in patients undergoing coronary artery bypass graft (CABG) surgery, but the causes of aspirin-resistance remain uncertain...

Keywords: CABG surgery, Aspirin, platelets, thromboxane A2

03/2006 | Thrombosis and Haemostasis, Schattauer

Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease

Tissue factor (TF) is the physiological initiating mechanism for blood coagulation. Platelets play an important role in monocyte TF expression, thrombosis and inflammation...

Keywords: Aspirin, Clopidogrel, Tissue factor, peripheral vascular disease, platelets

12/2006 | Thrombosis and Haemostasis, Schattauer

Glycoprotein Ib inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques

Anti-platelet drugs are used to prevent intra-arterial thrombus formation after rupture of atherosclerotic plaques...

Keywords: ADP receptor antagonists, Aspirin, GPIb, plaque, platelet thrombus formation

03/2007 | Thrombosis and Haemostasis, Schattauer

Inhibition of the ubiquitin-proteasome system: a new avenue for atherosclerosis

Background: The ubiquitin-proteasome system (UPS) is thought to be functionally active in atherosclerosis (AS) lesions...

Keywords: Aspirin, atherosclerosis, hypercholesterolemia, ubiquitin-proteasome system

10/2006 | Clinical Chemical Laboratory Medicine, Walter de Gruyter

Myocardial infarction in early pregnancy

Acute myocardial infarction (AMI) during pregnancy is usually transmural and occurs in late pregnancy with a peak incidence during the peripartum or postpartum periods...

Keywords: acute myocardial infarction, Aspirin, first trimester, low molecular weight heparin (LWMH), pregnancy

11/2004 | Journal of Perinatal Medicine, Walter de Gruyter

Aspirin-Resistenz / Aspirin resistance

Zusammenfassung

Acetylsalicylsäure (ASS) ist Grundlage der thrombozytenfunktionshemmenden Prävention atherothrombotischer Ereignisse...

Keywords: Acetylsalicylsäure, Cyclooxygenase, Thromboxan A2, Thrombozyten, Thrombozytenaggregation, Aspirin, platelet aggregation, platelets, thromboxane A2

10/2006 | LaboratoriumsMedizin, Walter de Gruyter

Publisher and Institutes